SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tom pope7/6/2009 2:43:49 PM
   of 7143
 
New Rules on Stem Cell Research Announced

By Shankar Vedantam
Washington Post Staff Writer
Monday, July 6, 2009 2:08 PM

The Obama administration today announced far-reaching new guidelines on the use of stem cells in medical research, and promised federal funds to study many of the hundreds of stem cell lines whose use was prohibited by the Bush administration.

President Obama had promised during the presidential campaign to ease restrictions on the use of stem cells in research, and has cited the promise of stem cell research in finding cures for disorders that have so far proven intractable.

The new guidelines were announced today by officials at the National Institutes of Health. In an important shift from draft guidelines issued April 23, the NIH announced that stem lines developed before the guidelines go into effect tomorrow -- Tuesday, July 7 -- will not need to meet the letter of new ethics requirements.

This means that the conflict of interest policy articulated earlier -- embryos must have been leftover from clinically necessary in-vitro fertilization procedures and full informed consent be given for their use -- be a rule that is observed in principle. Programs that did not adhere to the standard on procedural grounds, but did adhere to the spirit of the standard, will now be deemed permissible, with an NIH committee making a case by case decision. Officials stressed that only ethically derived stem cell lines would be eligible for federally funded research.

Announcing the new guidelines, Raynard S. Kington, the acting director of NIH, said that during the Bush years, privately funded researchers in the United States and a number of foreign laboratories had used a variety of protocols to obtain informed consent and meet other ethical requirements. He said it did not make sense to reject those stem cell lines merely because the ethics procedures used were different from the procedures that are required for new stem cell lines.

Kington said that an NIH committee comprised of scientists, ethicists and advocates will evaluate older stem cell lines one by one to see if they were derived using ethical principles.

The use of stem cells in research has become the subject of bitter national controversy, with advocates suggesting it is immoral for the federal government not to fund research that could save thousands of lives, and opponents arguing it is immoral to fund research that involves destroying embryos.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext